Evidence map›Paper›PMID 37393095›Full record

ArticleESMO open2023

Tobacco cessation and the role of ESMO and medical oncologists: addressing the specific needs of cancer patients in times of the COVID-19 pandemic.

R Krech, S Peters, H Kroemer, D Fu, R Giuliani, J Sehouli, A Ilbawi, V Prasad, A Ullrich

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in ESMO open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

R KrechHealth Promotion Department, World Health Organization, Geneva, Switzerland.
S PetersDepartment of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; European Society for Medical Oncology (ESMO), Lugano, Switzerland.
H KroemerExecutive Board Charité - Universitätmedizin, Berlin, Germany.
D FuHealth Promotion Department, World Health Organization, Geneva, Switzerland. Electronic address: fud@who.int.
R GiulianiEuropean Society for Medical Oncology (ESMO), Lugano, Switzerland; Guy's and St Thomas' NHS Foundation Trust, London, UK.
J SehouliDepartment of Gynaecology with Center for Oncological Surgery Charité - Universitätsmedizin Berlin, Germany.
A IlbawiDepartment of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland.
V PrasadHealth Promotion Department, World Health Organization, Geneva, Switzerland.
A UllrichDepartment of Gynaecology with Center for Oncological Surgery Charité - Universitätsmedizin Berlin, Germany.

Funding

World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19NeoplasmsOncologistsTobacco Use CessationHumansPandemics

Identifiers

PMID37393095
PMCPMC10229195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.